CarolynMBennettMDMSc
Pediatric Hematology & Oncology • Atlanta, GAAssistant Professor Aflac Cancer Center and Blood Disorders Service
Dr. Bennett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1405 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-785-1112Fax+1 404-785-6288
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1999
Yale-New Haven Medical CenterResidency, Pediatrics, 1992 - 1996
New York University School of MedicineClass of 1992
Certifications & Licensure
GA State Medical License 2006 - 2026
MA State Medical License 1996 - 2007
CT State Medical License 1995 - 1996- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Rituximab to Treat Severe Hemophilia A Start of enrollment: 2006 Jun 01
Publications & Presentations
PubMed
- Autoantibodies immuno-mechanically modulate platelet contractile force and bleeding risk.Oluwamayokun Oshinowo, Renee Copeland, Anamika Patel, Nina Shaver, Meredith E Fay
Nature Communications. 2024-11-25 - 3 citationsiCLOTS: open-source, artificial intelligence-enabled software for analyses of blood cells in microfluidic and microscopy-based assays.Meredith E Fay, Oluwamayokun Oshinowo, Elizabeth Iffrig, Kirby S Fibben, Christina Caruso
Nature Communications. 2023-08-18 - 5 citationsmTOR inhibition attenuates cTfh cell dysregulation and chronic T-cell activation in multilineage immune cytopenias.Deepak Kumar, Thinh H Nguyen, Carolyn M Bennett, Chengyu Prince, Laura Lucas
Blood. 2023-01-19
Abstracts/Posters
- Increased Platelet Force Is Associated with Decreased Bleeding Severity in Pediatric Immune ThrombocytopeniaCarolyn M. Bennett, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in ChildrenCarolyn M. Bennett, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- First Edition: June 13, 2022June 13th, 2022
- Feds to Meet Indigenous Leaders Friday to Discuss Racism in Health SystemOctober 16th, 2020
- Provinces Need to Address Racism in the Health-Care System: TrudeauOctober 16th, 2020
- Join now to see all
Grant Support
- Rituximab For Patients With Congenital Hemophilia ANational Center For Research Resources2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
